Hideki Tokaibayashi
Directeur/Bestuurslid bij TELLA, INC.
Actieve functies van Hideki Tokaibayashi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELLA, INC. | Directeur/Bestuurslid | 01-03-2021 | - |
| GranCharite Co. Ltd. | Directeur/Bestuurslid | 01-11-2017 | - |
Loopbaan van Hideki Tokaibayashi
Eerdere bekende functies van Hideki Tokaibayashi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REMIXPOINT, INC. | Directeur/Bestuurslid | 01-06-2020 | 28-06-2022 |
| Independent Dir/Board Member | 01-06-2020 | 28-06-2022 |
Statistieken
Internationaal
| Japan | 4 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Technology Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REMIXPOINT, INC. | Technology Services |
| Bedrijven in privébezit | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| GranCharite Co. Ltd. |
- Beurs
- Insiders
- Hideki Tokaibayashi
- Ervaring
